Meta-analysis of Medical Intervention for Normal Tension Glaucoma

Ophthalmology

Volumn 116, Issue 7, 2009, Pages 1243-1249

  Cheng, Jin Wei ^a   Cai, Ji Ping ^a   Wei, Rui Li ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETAXOLOL; BIMATOPROST; BRIMONIDINE; BRINZOLAMIDE; DORZOLAMIDE; LATANOPROST; PLACEBO; TIMOLOL; TRAVOPROST;

ARTICLE; CLINICAL TRIAL; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; EMBASE; EVENING DOSAGE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MEDLINE; META ANALYSIS; MONOTHERAPY; MORNING DOSAGE; NORMAL TENSION GLAUCOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMATIC REVIEW;

AGED; AMIDES; ANTIHYPERTENSIVE AGENTS; BETAXOLOL; CLOPROSTENOL; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PROSTAGLANDINS F, SYNTHETIC; QUINOXALINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SULFONAMIDES; THIAZINES; THIOPHENES; TIMOLOL; TONOMETRY, OCULAR;

EID: 67649359374     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.01.036     Document Type: Article

References (36)

1. Alward W.L. Medical management of glaucoma. N Engl J Med 339 (1998) 1298-1307
2. AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 130 (2000) 429-440
3. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 126 (1998) 487-497
4. Einarson T.R., Kulin N.A., Tingey D., and Iskedjian M. Meta-analysis of the effect of latanoprost and brimonidine on intraocular pressure in the treatment of glaucoma. Clin Ther 22 (2000) 1502-1515
5. Hodge W.G., Lachaine J., Steffensen I., et al. The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: a systematic review. Br J Ophthalmol 92 (2008) 7-12
6. Dubiner H.B., Sircy M.D., Landry T., et al. Comparison of the diurnal ocular hypotensive efficacy of travoprost and latanoprost over a 44-hour period in patients with elevated intraocular pressure. Clin Ther 26 (2004) 84-91
7. Parmaksiz S., Yuksel N., Karabas V.L., et al. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma. Eur J Ophthalmol 16 (2006) 73-80
8. van der Valk R., Webers C.A., Schouten J.S., et al. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials. Ophthalmology 112 (2005) 1177-1185
9. Verhagen A.P., de Vet H.C., de Bie R.A., et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 51 (1998) 1235-1241
10. DerSimonian R., and Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28 (2007) 105-114
11. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
12. Harris A., Spaeth G.L., Sergott R.C., et al. Retrobulbar arterial hemodynamic effects of betaxolol and timolol in normal-tension glaucoma. Am J Ophthalmol 120 (1995) 168-175
13. Rulo A.H., Greve E.L., Geijssen H.C., and Hoyng P.F. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma. Ophthalmology 103 (1996) 1276-1282
14. Drance S.M., Crichton A., and Mills R.P. Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma. Am J Ophthalmol 125 (1998) 585-592
15. Harris A., Arend O., Kagemann L., et al. Dorzolamide, visual function and ocular hemodynamics in normal-tension glaucoma. J Ocul Pharmacol Ther 15 (1999) 189-197
16. Harris A., Arend O., Chung H.S., et al. A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal-tension glaucoma patients. Ophthalmology 107 (2000) 430-434
17. Liu C.J., Ko Y.C., Cheng C.Y., et al. Changes in intraocular pressure and ocular perfusion pressure after latanoprost 0.005% or brimonidine tartrate 0.2% in normal-tension glaucoma patients. Ophthalmology 109 (2002) 2241-2247
18. Gandolfi S.A., Cimino L., and Mora P. Effect of brimonidine on intraocular pressure in normal tension glaucoma: a short term clinical trial. Eur J Ophthalmol 13 (2003) 611-615
19. Harris A., Migliardi R., Rechtman E., et al. Comparative analysis of the effects of dorzolamide and latanoprost on ocular hemodynamics in normal tension glaucoma patients. Eur J Ophthalmol 13 (2003) 24-31
20. Liu C.J., Cheng C.Y., Ko Y.C., and Hsu W.M. Diurnal intraocular pressure and blood pressure with two dosing regimens of brimonidine in normal tension glaucoma. J Chin Med Assoc 67 (2004) 465-471
21. Tomita G., Araie M., Kitazawa Y., and Tsukahara S. A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients. Eye 18 (2004) 984-989
22. Zeitz O., Matthiessen E.T., Reuss J., et al. Effects of glaucoma drugs on ocular hemodynamics in normal tension glaucoma: a randomized trial comparing bimatoprost and latanoprost with dorzolamide [ISRCTN18873428]. BMC Ophthalmol [serial online] 5 (2005) 6. http://www.biomedcentral.com/1471-2415/5/6 Accessed January 6, 2009
23. Dirks M.S., Noecker R.J., Earl M., et al. A 3-month clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with normal-tension glaucoma. Adv Ther 23 (2006) 385-394
24. Kiuchi T., Motoyama Y., and Oshika T. Influence of ocular hypotensive eyedrops on intraocular pressure fluctuation with postural change in eyes with normal-tension glaucoma. Am J Ophthalmol 143 (2007) 693-695
25. Costagliola C., Parmeggiani F., Virgili G., et al. Circadian changes of intraocular pressure and ocular perfusion pressure after timolol or latanoprost in Caucasians with normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol 246 (2008) 389-396
26. Quaranta L., Pizzolante T., Riva I., et al. Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma. Br J Ophthalmol 92 (2008) 1227-1231
27. Maier P.C., Funk J., Schwarzer G., et al. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. BMJ 331 (2005) 134. http://www.bmj.com/cgi/content/full/331/7509/134 Accessed January 6, 2009
28. Netland P.A., Landry T., Sullivan E.K., et al., Travoprost Study Group. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol 132 (2001) 472-484
29. Noecker R.S., Dirks M.S., Choplin N.T., et al., Bimatoprost/Latanoprost Study Group. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol 135 (2003) 55-63
30. Konstas A.G., Holló G., Irkec M., et al. Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study. Br J Ophthalmol 91 (2007) 757-760
31. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 126 (1998) 498-505
32. Olthoff C.M., Schouten J.S., van de Borne B.W., and Webers C.A. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension: an evidence-based review. Ophthalmology 112 (2005) 953-961
33. Yamagami J., Araie M., Aihara M., and Yamamoto S. Diurnal variation in intraocular pressure of normal-tension glaucoma eyes. Ophthalmology 100 (1993) 643-650
34. Kano K., and Kuwayama Y. Diurnal variation of intraocular pressure in normal-tension glaucoma [in Japanese]. Nippon Ganka Gakkai Zasshi 107 (2003) 375-379
35. Hasegawa K., Ishida K., Sawada A., et al. Diurnal variation of intraocular pressure in suspected normal-tension glaucoma. Jpn J Ophthalmol 50 (2006) 449-454
36. Acheampong A.A., Shackleton M., and Tang-Liu D.D. Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits. Drug Metab Dispos 23 (1995) 708-712